Induction of G(1) checkpoint in the gastric mucosa of aged rats.
Although in Fischer 344 rats aging is found to be associated with increased gastric mucosal proliferative activity, little is known about specific changes in the regulatory mechanisms of this process. To determine whether changes in cell cycling events could partly contribute to the age-related rise in gastric mucosal proliferative activity, the present investigation examines changes in cyclin-dependent kinase (Cdk2) activity and the regulation of this process in the gastric mucosa of Fischer 344 rats aged 4 (young), 13 (middle aged), and 24 (old) mo. We observed that aging is associated with a progressive rise in activity and protein levels of Cdk2 in the gastric mucosa. This is also found to be accompanied by a concomitant increase in cyclin E but not cyclin D1 levels. On the other hand, the levels of p21(Waf1/Cip1) (total as well as the fraction associated with Cdk2), a nuclear protein that is known to inhibit different cyclin-Cdk complexes, are found to decline in the gastric mucosa with advancing age. In contrast, with aging, there was a steady rise in p53 levels in the gastric mucosa. We have also observed that the levels of phosphorylated retinoblastoma protein, a form that participates in regulating progression through the S phase, are markedly elevated in the gastric mucosa of aged rats. In conclusion, our data suggest that, in the gastric mucosa, aging enhances transition of G(1) to S phase as well as progression through the S phase of the cell cycle. However, the age-related decline in p21(Waf1/Cip1) in the gastric mucosa appears to be independent of p53 status.
Xiao
Z Q
ZQ
Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
Yu
Y
Y
Khan
A
A
Jaszewski
R
R
Ehrinpreis
M N
MN
Majumdar
A P
AP
D000375:Aging / Q000502:physiology*; D000818:Animals; D015153:Blotting, Western; D042846:CDC2-CDC28 Kinases; D019938:Cyclin D1 / Q000032:analysis / Q000378:metabolism; D019927:Cyclin E / Q000032:analysis / Q000378:metabolism; D051357:Cyclin-Dependent Kinase 2; D050759:Cyclin-Dependent Kinase Inhibitor p21; D018844:Cyclin-Dependent Kinases / Q000032:analysis / Q000378:metabolism; D016213:Cyclins / Q000032:analysis / Q000378:metabolism; D004789:Enzyme Activation / Q000502:physiology; D016193:G1 Phase / Q000502:physiology*; D005753:Gastric Mucosa / Q000166:cytology* / Q000201:enzymology; D008297:Male; D017346:Protein Serine-Threonine Kinases / Q000032:analysis / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D016160:Retinoblastoma Protein / Q000032:analysis / Q000378:metabolism; D016196:S Phase / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
C493958:Cdkn1a protein, rat; D019927:Cyclin E; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D016160:Retinoblastoma Protein; D016159:Tumor Suppressor Protein p53; D019938:Cyclin D1; D017346:Protein Serine-Threonine Kinases; D042846:CDC2-CDC28 Kinases; C495892:Cdk2 protein, rat; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases